Is there a role for B lymphocyte chimerism in the monitoring of B-acute lymphoblastic leukemia patients receiving allogeneic stem cell transplantation?

Is there a role for B lymphocyte chimerism in the monitoring of B-acute lymphoblastic leukemia patients receiving allogeneic stem cell transplantation?

Objective: To determine the sensitivity and significance of B-cell chimerism for the detection of early engraftment, transplant rejection, and disease relapse. Methods: The dynamic monitoring of lineage-specific cell subtypes (B, T, and NK cells) was made in 20 B-cell acute lymphoblastic leukemia (B...

Full description

Bibliographic Details
Main Authors:	Yi-Ning Yang, Xiao-Rui Wang, You-Wen Qin, Li-Ping Wan, Ying Jiang, Chun Wang
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2015-03-01
Series:	Chronic Diseases and Translational Medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2095882X15000055

Similar Items

Allogeneic stem Cell Transplantation outcome in acute Lymphoblastic Leukemia Patients
by: Kamran Alimoghaddam, et al.
Published: (2015-10-01)

Allogeneic stem Cell Transplantation outcome in acute Lymphoblastic Leukemia Patients
by: Kamran Alimoghaddam, et al.
Published: (2012-10-01)

ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
by: Patrizia Chiusolo, et al.
Published: (2010-05-01)

ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
by: Luca Laurenti, et al.
Published: (2010-08-01)

ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
by: Federico Lussana, et al.
Published: (2014-10-01)

How to Combine the Two Landmark Treatment Methods—Allogeneic Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Together to Cure High-Risk B Cell Acute Lymphoblastic Leukemia?
by: Mingming Zhang, et al.
Published: (2020-12-01)

Molecular Diagnostics, Targeted Therapy, and the Indication for Allogeneic Stem Cell Transplantation in Acute Lymphoblastic Leukemia
by: Anthony Oyekunle, et al.
Published: (2011-01-01)

Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation
by: Chen R, et al.
Published: (2015-02-01)

Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
by: Ciprian Tomuleasa, et al.
Published: (2018-02-01)

Donor-Derived CD19-Targeted T Cell Infusion Eliminates B Cell Acute Lymphoblastic Leukemia Minimal Residual Disease with No Response to Donor Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation
by: Yifei Cheng, et al.
Published: (2019-02-01)

Donor Chimerism of B Cells and Nature Killer Cells Provides Useful Information to Predict Hematologic Relapse following Allogeneic Hematopoietic Stem Cell Transplantation.
by: Ying Jiang, et al.
Published: (2015-01-01)

Influence of patient characteristics on chimeric antigen receptor T cell therapy in B-cell acute lymphoblastic leukemia
by: Furun An, et al.
Published: (2020-11-01)

A risk score system for stratifying the risk of relapse in B cell acute lymphocytic leukemia patients after allogenic stem cell transplantation
by: Le-Qing Cao, et al.
Published: (2021-05-01)

Eradication of Pulmonary Aspergillosis in an Adolescent Patient Undergoing Three Allogeneic Stem Cell Transplantations for Acute Lymphoblastic Leukemia
by: Michaela Döring, et al.
Published: (2012-01-01)

Isolated skin relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplant
by: Masumi Ueda, et al.

Tyrosine Kinase Inhibitor for Treatment of Adult Allogeneic Hematopoietic Stem Cell Transplantation Candidate with Philadelphia-Positive Acute Lymphoblastic Leukemia
by: Lu Wang, et al.
Published: (2017-01-01)

Advances in the development of chimeric antigen receptor-T-cell therapy in B-cell acute lymphoblastic leukemia
by: Xian Zhang, et al.
Published: (2020-02-01)

Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions
by: Uri Greenbaum, et al.
Published: (2020-08-01)

Allogeneic Hematopoietic Stem Cell Transplantation for a BCR-FGFR1 Myeloproliferative Neoplasm Presenting as Acute Lymphoblastic Leukemia
by: Karl Haslam, et al.
Published: (2012-01-01)

Allogeneic stem cell transplantation for acute myeloid leukemia with del(7q) following untreated chronic lymphocytic leukemia
by: Zachariah DeFilipp, et al.
Published: (2012-07-01)

First case of near haploid philadelphia negative B-Cell acute lymphoblastic leukaemia relapsing as acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
by: Claire Horgan, et al.
Published: (2020-01-01)

Extramedullary relapse of acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation treated by CAR T-cell therapy: a case report
by: Wang D, et al.
Published: (2018-09-01)

Allogeneic stem cell transplantation in acute myeloid leukemia
by: Natasha Ali, et al.
Published: (2012-11-01)

Allogeneic hematopoietic stem cells transplantation with reduced intensity conditioning regimen in children and adolescents with unfavorable forms of acute lymphoblastic leukemia
by: E. V. Semenova, et al.
Published: (2014-07-01)

Allogeneic Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Results from a Single Center, 1993-2011
by: Ipek Yonal-Hindilerden, et al.
Published: (2016-12-01)

Allogeneic hematopoietic stem cells transplantation with reduced intensity conditioning regimen in children and adolescents with unfavorable forms of acute lymphoblastic leukemia
by: E. V. Semenova, et al.
Published: (2014-07-01)

DONOR CHIMERISM IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION
by: V. A. Lavrinenko, et al.
Published: (2018-07-01)

Strategies and Clinical Implications of Chimerism Diagnostics after Allogeneic Hematopoietic Stem Cell Transplantation
by: Thiede, Christian, et al.
Published: (2014)

Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia
by: Yan-Li Zhao, et al.
Published: (2021-05-01)

Expression of B lymphocyte antigen in pediatric B-cell precursor acute lymphoblastic leukemia: AIIMS Experience
by: Nivedita Pathak, et al.
Published: (2016-01-01)

The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia
by: Mattia Algeri, et al.
Published: (2021-08-01)

Outcome of allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia in second complete remission: a single institution study
by: Eun-Jung Lee, et al.
Published: (2012-03-01)

Venetoclax in Combination with Decitabine for Relapsed T-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplant
by: Leena T. Rahmat, et al.
Published: (2018-01-01)

Quantitative analysis of chimerism after allogeneic hematopoietic stem cell transplantation with molecular genetic methods
by: V. A. Lavrinenko, et al.
Published: (2014-09-01)

Digital PCR Panel for Sensitive Hematopoietic Chimerism Quantification after Allogeneic Stem Cell Transplantation
by: Tanja Stahl, et al.
Published: (2016-09-01)

Quantitative analysis of chimerism after allogeneic hematopoietic stem cell transplantation with molecular genetic methods
by: V. A. Lavrinenko, et al.
Published: (2014-09-01)

Chimerism analysis in isolated cell populations after allogeneic hematopoietic stem cell transplantation in children
by: Rascon, Jelena
Published: (2009)

Maintenance Treatment With Low-Dose Decitabine After Allogeneic Hematopoietic Cell Transplantation in Patients With Adult Acute Lymphoblastic Leukemia
by: Jia Liu, et al.
Published: (2021-08-01)

GMP-production of purified human B lymphocytes for the adoptive transfer in patients after allogeneic hematopoietic stem cell transplantation
by: Hannes Tittlbach, et al.
Published: (2017-11-01)

MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
by: Elena Maino, et al.
Published: (2015-01-01)

Cannot write session to /tmp/vufind_sessions/sess_n0ari3nlqllbrn06bnftj9cvib